Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease

Journal of Clinical Investigation

Volumn 108, Issue 4, 2001, Pages 591-599

  Hauben, E ^a   Agranov, E ^a   Gothilf, A ^a   Nero, U ^a   Cohen, A ^a   Smirnov, I ^a   Steinman, L ^a   Schwartz, M ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN;

ACTIVE IMMUNIZATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CONTUSION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARALYSIS; PRIORITY JOURNAL; RAT; RUBROSPINAL TRACT; SPINAL CORD INJURY; VACCINATION;

EID: 0034893791     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12837     Document Type: Article

References (43)

1. Mediators of injury in neurotrauma: Intracellular signal transduction and gene expression
2. Experimental neurobiology of central nervous system trauma
3. Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: Electrophysiological, histological, and neurochemical results
4. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
5. Autoimmune T cells as potential neuroprotective therapy for spinal cord injury
6. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection
7. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: Neuroprotection and local regeneration
8. Endogenous repair after spinal cord contusion injuries in the rat
9. Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673
10. Systemically administered interleukin-10 reduces rumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
11. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
12. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats
13. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
14. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury
15. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion
16. Innate and adaptive immune responses can be beneficial for CNS repair
17. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response
18. Protective autoimmunity is a physiological response to CNS trauma
19. Autoimmune maintenance and neuroprotection of the central nervous system
20. Autoimmunity can benefit self-maintenance
21. Vaccination for neuroprotection in the mouse optic nerve: Implications for optic neuropathies
22. Protective autoimmunity: Regulation and prospect for vaccination after brain and spinal cord injuries
23. Morphological aspects of spinal cord autoimmune neuroprotection-colocalization of T cells with B7-2 (CD86 and prevention of cyst formation)
24. Spinal cord regeneration
25. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats
26. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells
27. A sensitive and reliable locomotor rating scale for open field resting in rats
28. Diffusion anisotropy MRI for quantitative assessment of recovery in injured rat spinal cord
29. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis
30. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant
31. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord
32. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms
33. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99)
34. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
35. Autoimmunity counteracts the potential toxicity of physiological compounds in the central nervous system
36. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis
37. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
38. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand
39. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
40. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: Implications for autoimmunity
41. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
42. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies
43. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma